<DOC>
	<DOCNO>NCT00004261</DOCNO>
	<brief_summary>RATIONALE : EF5 may detect presence oxygen tumor cell help plan effective cancer treatment . PURPOSE : Phase I trial study effectiveness EF5 detect presence oxygen tumor cell patient undergo surgery biopsy breast , prostate , cervical cancer high grade soft tissue sarcoma .</brief_summary>
	<brief_title>EF5 Prior Surgery Biopsy Patients With Breast , Prostate , Cervical Cancer High Grade Soft Tissue Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine optimal dose etanidazole derivative EF5 safely tolerate provide optimal bind resected tumor specimen tumor biopsy patient breast , head neck , prostate , cervical carcinoma high grade soft tissue sarcoma . II . Define toxic effect EF5 patient population . OUTLINE : This dose-escalation study . Patients receive etanidazole derivative EF5 IV 1-2 hour . Approximately 24-48 hour EF5 treatment , patient undergo surgical resection biopsy tumor . Cohorts 6 patient receive escalate dos EF5 maximum tolerate dose ( MTD ) optimal dose determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . The optimal dose define dose level precede MTD result optimal tumor-to-normal-tissue binding . Patients follow 28 day . PROJECTED ACCRUAL : A total 18-36 patient accrue study within 12-18 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven breast , head neck , prostate , cervical carcinoma high grade ( define grade 2 3 ) soft tissue sarcoma Sarcoma tumor must confine truncal extremity location Must clinical condition physiologic status demonstrate appropriate standard initial therapy tumor surgical biopsy resection Tumors great 15 cm diameter Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Menopausal status : Not specify Performance status : ECOG 0 1 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 2,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 2.0 mg/dL Renal : Creatinine le 2.0 mg/dL OR Creatinine clearance great 50 mL/min Cardiovascular : No significant cardiac disease would preclude safe use general anesthesia Pulmonary : No significant pulmonary disease would preclude safe use general anesthesia Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 1 month study No grade 3 4 peripheral neuropathy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>breast cancer situ</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage 0 cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IA cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>inflammatory breast cancer</keyword>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I nasopharyngeal cancer</keyword>
	<keyword>stage II nasopharyngeal cancer</keyword>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>recurrent nasopharyngeal cancer</keyword>
	<keyword>stage 0 paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage 0 nasopharyngeal cancer</keyword>
	<keyword>stage 0 oropharyngeal cancer</keyword>
	<keyword>stage 0 laryngeal cancer</keyword>
	<keyword>stage 0 hypopharyngeal cancer</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage 0 lip oral cavity cancer</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>stage I lip oral cavity cancer</keyword>
	<keyword>stage II lip oral cavity cancer</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>recurrent lip oral cavity cancer</keyword>
	<keyword>stage I hypopharyngeal cancer</keyword>
	<keyword>stage II hypopharyngeal cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>recurrent hypopharyngeal cancer</keyword>
	<keyword>stage I laryngeal cancer</keyword>
	<keyword>stage II laryngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage IV laryngeal cancer</keyword>
	<keyword>recurrent laryngeal cancer</keyword>
	<keyword>stage I paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage II paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage IV paranasal sinus nasal cavity cancer</keyword>
	<keyword>recurrent paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage I oropharyngeal cancer</keyword>
	<keyword>stage II oropharyngeal cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>recurrent oropharyngeal cancer</keyword>
	<keyword>stage II adult soft tissue sarcoma</keyword>
	<keyword>stage I adult soft tissue sarcoma</keyword>
</DOC>